Immunovia receives regulatory approval for Pancreasure test in California. Douglas reports Q1 sales in line with estimates, faces margin pressure from consumer price sensitivity. Marshalls PLC expects 2025 adjusted profit before tax to align with market expectations. Bayer's stock rises as U.S. Supreme Court agrees to review Roundup litigation. Zurich Insurance increases bid for Beazley to 1,280 pence per share. Engie reaches financial close on 1.5 GW solar PV project in Abu Dhabi, marking MENA growth. UniCredit provides €73 million green loan to Pioneer Infrastructure Partners' Teike, backed by SACE green guarantee. Cheffelo AB reports 25% year-over-year increase in Q4 operating profit, approximately 36.8 million SEK. ASM International reports stronger-than-expected Q4 bookings of approximately €800 million, driven by Chinese orders rebound. Rest of the world: Everstone Capital to divest stake in Restaurant Brands Asia, allowing Ajanta Pharma's family office to become a strategic investor. Wipro shares drop 7% due to disappointing Q4 revenue forecast and lackluster deal wins. Elliott Investment Management opposes Toyota Fudosan's revised tender offer for Toyota Industries Corp. BHEL experiences 16% increase in Q3 revenue due to robust power equipment sales and strong order pipeline. © MarketScreener.com - 2026